naringenin has been researched along with Pancreatic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Awale, S; Esumi, H; Kadota, S; Li, F; Onozuka, H; Tezuka, Y | 1 |
| Awale, S; Esumi, H; Kadota, S; Li, F; Tezuka, Y | 1 |
| Akhter, MH; Kumar, S; Nomani, S | 1 |
| Kim, DH; Kim, JH; Lee, J | 1 |
| Choi, YJ; Lee, JH; Nam, MJ; Park, HJ | 1 |
| Abrantes, M; Duarte, N; Ferreira, MJ; Lage, H | 1 |
| Fang, X; Liang, W; Lou, C; Yang, M; Zeng, W; Zhang, C; Zhang, F; Zhang, Y; Zhao, J | 1 |
7 other study(ies) available for naringenin and Pancreatic Neoplasms
| Article | Year |
|---|---|
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Necrosis; Nutritional Requirements; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Propolis; Sensitivity and Specificity | 2008 |
Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bees; Drug Screening Assays, Antitumor; Flavonoids; Humans; Mexico; Molecular Structure; Pancreatic Neoplasms; Propolis; Stereoisomerism | 2010 |
Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Drug Stability; Flavanones; Humans; Nanoparticles; Pancreatic Neoplasms; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Sonication | 2020 |
Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Citrus; Down-Regulation; Flavanones; Focal Adhesion Kinase 1; Hesperidin; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Pancreatic Neoplasms; Phosphorylation; Xenograft Model Antitumor Assays | 2019 |
Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells.
Topics: Apoptosis; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Estrogen Antagonists; Flavanones; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Peptide Fragments; Peroxiredoxins; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2017 |
Phenolic compounds as selective antineoplasic agents against multidrug-resistant human cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Multiple; Euphorbia; Flavanones; Humans; Lignans; Magnoliopsida; Myristicaceae; Neoplasms; Pancreatic Neoplasms; Phenols; Phytotherapy; Plant Extracts; Stilbenes; Stomach Neoplasms | 2010 |
Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells.
Topics: Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Estrogen Antagonists; Flavanones; Gemcitabine; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; Phosphorylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Tumor Cells, Cultured; Wound Healing | 2012 |